A real-world study of interleukin-6 receptor blockade in patients with neuromyelitis optica spectrum...
A real-world study of interleukin-6 receptor blockade in patients with neuromyelitis optica spectrum disorder
About this item
Full title
Author / Creator
Yang, Shu , Zhang, Chen , Zhang, Tian-Xiang , Feng, Bin , Jia, Dongmei , Han, Shasha , Li, Ting , Shen, Yi , Yan, Guangxun and Zhang, Chao
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease that can cause permanent neurological disabilities. However, the interleukin-6 (IL-6) signaling pathway is a promising therapeutic target for relapse prevention. Therefore, this study evaluated the long-term effectiveness of tocilizumab, a humanized anti-IL-6 receptor...
Alternative Titles
Full title
A real-world study of interleukin-6 receptor blockade in patients with neuromyelitis optica spectrum disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2760705867
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2760705867
Other Identifiers
ISSN
0340-5354,1432-1459
E-ISSN
1432-1459
DOI
10.1007/s00415-022-11364-9
